US 8147840
Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid
granted A61KA61K2039/505A61K2039/53
Quick answer
US patent 8147840 (Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K2039/53, A61K2039/555, A61K2039/6056